Compare Danaher Corporation (DHR) vs iShares MSCI Indonesia ETF (EIDO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs iShares MSCI Indonesia ETF — how do they compare? Danaher Corporation trades at $199.47 (market cap $141.67B), while iShares MSCI Indonesia ETF trades at $12. The key difference: Danaher Corporation pays a 0.8% dividend while iShares MSCI Indonesia ETF pays none, and Danaher Corporation is trading nearer its 52-week high, iShares MSCI Indonesia ETF nearer its low. Which is the better fit depends on your goals.
| DHR | EIDO | |
|---|---|---|
Market Cap | $141.67B | — |
Sector | Health | — |
52-Week High | $242.05 | $19.22 |
52-Week Low | $161.91 | $10.80 |
Enterprise Value | $154.45B | — |
Dividend Yield | 0.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $199.05, showing minimal daily change, with a bullish technical signal supported by moving averages. The company maintains strong profitability with a 58.94% gross margin and has beaten earnings estimates for the last three quarters. Recent news highlights the acquisition of Masimo and new product launches in its SCIEX division, indicating growth initiatives. Cash flow improved in 2025 to a net inflow of $2.54 billion, though revenue growth remains modest.
The outlook is positive with a consensus price target of $211.33, representing a 6% upside, and 69% of analysts rate it a buy. Risks include slowing revenue growth, high valuation multiples, and integration challenges from acquisitions. The stock offers a dividend yield supported by stable cash flows, but investors should monitor competitive pressures in the life sciences sector.
EIDO, the iShares MSCI Indonesia ETF, trades at $11.98, up 1.1% on the day, but technical indicators signal a bearish trend with moving averages and RSI_6 suggesting caution. Key financial ratios are unavailable, but recent news highlights Indonesia's economic initiatives, including a $15 billion AI-integrated free-meal program and central bank rate hikes to support the rupiah. The ETF's dividend dropped 27% in 2025, indicating potential income instability for investors.
The outlook for EIDO is mixed, with opportunities from Indonesia's GDP growth potential but risks from currency volatility and dividend cuts. Investors face headwinds from bearish technical signals and macroeconomic pressures, requiring careful assessment of emerging market exposure amid fluctuating sentiment and limited fundamental data.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About iShares MSCI Indonesia ETF
The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Indonesia. The fund is non-diversified.
Read more on EIDO →
